P-31 NMR INVESTIGATIONS OF PHOSPHORAMIDE MUSTARD - EVALUATION OF PH CONTROL OVER THE RATE OF INTRA-MOLECULAR CYCLIZATION TO AN AZIRIDINIUM ION AND THE HYDROLYSIS OF THIS REACTIVE ALKYLATOR

被引:23
作者
ENGLE, TW
ZON, G
EGAN, W
机构
[1] CATHOLIC UNIV AMER,DEPT CHEM,WASHINGTON,DC 20064
[2] US FDA,BUR BIOL,DIV BACTERIAL PROD,BETHESDA,MD 20205
关键词
D O I
10.1021/jm00194a001
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The metabolic transformations shown in Scheme I for the anticancer drug cyclophosphamide (1)1 are generally viewed as an initial “activation step” (1 → 2/3) which is followed by partitioning of the primary metabolites among competing toxification (2/3 → 4/5) and reversible deactivation2 (2/3 → 6) pathways. Causal relationships between these events and the oncostatic specificity of 1 have not as yet been clearly established; however, the toxicity of phosphoramide mustard (5)3 is reasonably associated with DNA cross-linking.4, 5 Friedman6 originally rationalized the high alkylating reactivity of 5 in terms of an electronically enhanced rate of intramolecular cyclization of conjugate base 5b to form aziridinium ion 7 (Scheme I), the trapping of which has been recently reported by Colvin et al.7 The influence of pH on the alkylating activity of 5 has been recognized as an important reactivity feature;6-9 however, details in this connection have been heretofore unavailable. This lack of fundamental information concerning cyclophosphamide's ultimate alkylating metabolites prompted our investigation of 5 by high-resolution NMR, and we now report preliminary31P NMR measurements which accurately define the pH-rate profile for 5 → 7 and also reveal a striking pH dependency for subsequent hydrolytic reactions of 7. These findings bear upon numerous recent studies involving 52, 5, 7, 10-14 and provide the basis for a new perspective from which the oncostatic specificity of 1 may be considered. © 1979, American Chemical Society. All rights reserved.
引用
收藏
页码:897 / 898
页数:2
相关论文
共 18 条
[1]  
COLVIN M, 1976, CANCER RES, V36, P1121
[2]  
FENSELAU C, 1975, CANCER RES, V35, P1453
[3]   SYNTHESIS OF N-PHOSPHORYLATED DERIVATIVES OF NITROGEN MUSTARDS WITH LATENT CYTOTOXICITY [J].
FRIEDMAN, OM ;
BOGER, E ;
SOMMER, H ;
GRUBLIAUSKAS, V .
JOURNAL OF MEDICINAL CHEMISTRY, 1963, 6 (01) :50-+
[4]  
FRIEDMAN OM, 1979, ADV CANC CHEMOTHERAP, P143
[5]  
FRIEDMAN ORRIE M., 1967, CANCER CHEMO THER REPSYMPOSIUM ON CYCLOPHOSPHAMIDE IN PEDIATRIC NEOPLASIA, V51, P347
[6]   STUDIES ON BINDING OF [H-3-CHLOROETHYL]-CYCLOPHOSPHAMIDE AND (C-4)-14-CYCLOPHOSPHAMIDE TO HEPATIC MICROSOMES AND NATIVE CALF THYMUS DNA [J].
GURTOO, HL ;
DAHMS, R ;
HIPKENS, J ;
VAUGHT, JB .
LIFE SCIENCES, 1978, 22 (01) :45-52
[7]  
HILL DL, 1975, REV CYCLOPHOSPHAMIDE
[8]  
HOUGHTON PJ, 1976, CANCER TREAT REP, V60, P459
[9]  
LEVINS P. L., 1965, CANCER CHEMOTHERAP REP, V44, P15
[10]   KINETICS OF CARBOXYPEPTIDASE ACTION .1. EFFECT OF VARIOUS EXTRINSIC FACTORS ON KINETIC PARAMETERS [J].
LUMRY, R ;
SMITH, EL ;
GLANTZ, RR .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1951, 73 (09) :4330-4340